Maria Stepanova

Sitert av

	Alle	Siden 2020
Sitater	19295	10290
h-indeks	64	47
i10-indeks	177	137

2100

1050

525

1575

2009201020112012201320142015201620172018201920202021202220232024202572 122 241 344 435 649 863 1131 1333 1785 1720 1820 1995 2035 2015 1968 436

Offentlig tilgang

Vis alle

15 artikler

2 artikler

tilgjengelige

ikke tilgjengelige

Basert på finansieringsmandater

Medforfattere

Zobair YounossiThe Global NASH CouncilVerifisert e-postadresse på cldq.org
Zachary GoodmanInova Fairfax Medical CampusVerifisert e-postadresse på inova.org
Andrei RacilaGlobal NASH Council / Inova Health SystemVerifisert e-postadresse på cldq.org
Ancha Baranova, Анча БарановаProfessor, School of Systems Biology, George Mason UniversityVerifisert e-postadresse på gmu.edu
Aybike BirerdincResearch Assistant Professor, George Mason UniversityVerifisert e-postadresse på gmu.edu
Pegah GolabiDoctor of Medicine, Betty and Guy Beatty Center for Integrated Research, Inova Health System, FallsVerifisert e-postadresse på inova.org
Michael EstepScientist, Inova Health SystemVerifisert e-postadresse på inova.org
Janus OngAssociate Professor, University of the Philippines College of MedicineVerifisert e-postadresse på up.edu.ph
Vikas ChandhokeGeorge Mason UniversityVerifisert e-postadresse på gmu.edu
Saleh A AlqahtaniKing Faisal Specialist Hospital and Research CentreVerifisert e-postadresse på jhmi.edu
Vincent Wai-Sun WongThe Chinese University of Hong KongVerifisert e-postadresse på mect.cuhk.edu.hk
Prof Dr Yusuf YılmazRecep Tayyip Erdogan UniversityVerifisert e-postadresse på marmara.edu.tr
Jillian Kallman Price, PhDBetty & Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, VA, USA.Verifisert e-postadresse på inova.org
Ajay DusejaHepatology, PGIMER, ChandigarhVerifisert e-postadresse på pgimer.edu.in
Nezam AfdhalProfessor of Medicine, Harvard Medical SchoolVerifisert e-postadresse på bidmc.harvard.edu
Francesco NegroProfessor, University Hospitals of GenevaVerifisert e-postadresse på hcuge.ch
Kris KowdleyDirector, Liver Institute NorthwestVerifisert e-postadresse på liverinstitutenw.org
Professor Mohammed H. JarrarProfessor of Medical Biotechnology, Senior Manager of Medical & Health Research, QNRF, QATARVerifisert e-postadresse på qnrf.org
Jacob GeorgeUniversity of Sydney, Westmead Millennium Institute, Westmead Hospital, University of QueenslandVerifisert e-postadresse på sydney.edu.au
Mark S. Sulkowski, MDProfessor of Medicine; Johns Hopkins University School of MedicineVerifisert e-postadresse på jhmi.edu

Følg

Maria Stepanova

Director of Statistical Services, COR-LD

Verifisert e-postadresse på cldq.org

metabolic diseases clinical trials


Tittel Sorter etter sitater Sorter etter år Sorter etter tittel	Sitert av Sitert av	År
Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008 ZM Younossi, M Stepanova, M Afendy, Y Fang, Y Younossi, H Mir, ... Clinical gastroenterology and hepatology 9 (6), 524-530. e1, 2011	1485	2011
The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe ZM Younossi, D Blissett, R Blissett, L Henry, M Stepanova, Y Younossi, ... Hepatology 64 (5), 1577-1586, 2016	1389	2016
Nonalcoholic steatohepatitis is the fastest growing cause of hepatocellular carcinoma in liver transplant candidates Z Younossi, M Stepanova, JP Ong, IM Jacobson, E Bugianesi, A Duseja, ... Clinical gastroenterology and hepatology 17 (4), 748-755. e3, 2019	763	2019
Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver‐related mortality ZM Younossi, M Stepanova, N Rafiq, H Makhlouf, Z Younoszai, ... Hepatology 53 (6), 1874-1882, 2011	752	2011
Nonalcoholic fatty liver disease in lean individuals in the United States ZM Younossi, M Stepanova, F Negro, S Hallaji, Y Younossi, B Lam, ... Medicine 91 (6), 319-327, 2012	674	2012
Adipokines and cytokines in non‐alcoholic fatty liver disease MH Jarrar, A Baranova, R Collantes, B Ranard, M Stepanova, C Bennett, ... Alimentary pharmacology & therapeutics 27 (5), 412-421, 2008	628	2008
Epidemiology of chronic liver diseases in the USA in the past three decades ZM Younossi, M Stepanova, Y Younossi, P Golabi, A Mishra, N Rafiq, ... Gut 69 (3), 564-568, 2020	507	2020
Extrahepatic manifestations of hepatitis C: a meta-analysis of prevalence, quality of life, and economic burden Z Younossi, H Park, L Henry, A Adeyemi, M Stepanova Gastroenterology 150 (7), 1599-1608, 2016	488	2016
Nonalcoholic steatohepatitis is the most rapidly increasing indication for liver transplantation in the United States ZM Younossi, M Stepanova, J Ong, G Trimble, S AlQahtani, I Younossi, ... Clinical Gastroenterology and Hepatology 19 (3), 580-589. e5, 2021	462	2021
Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population M Stepanova, ZM Younossi Clinical Gastroenterology and Hepatology 10 (6), 646-650, 2012	445	2012
Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease N Hossain, A Afendy, M Stepanova, F Nader, M Srishord, N Rafiq, ... Clinical Gastroenterology and Hepatology 7 (11), 1224-1229. e2, 2009	419	2009
Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study M Stepanova, N Rafiq, ZM Younossi Gut 59 (10), 1410-1415, 2010	381	2010
A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH) ZM Younossi, M Jarrar, C Nugent, M Randhawa, M Afendy, M Stepanova, ... Obesity surgery 18, 1430-1437, 2008	350	2008
Predictors of all-cause mortality and liver-related mortality in patients with non-alcoholic fatty liver disease (NAFLD) M Stepanova, N Rafiq, H Makhlouf, R Agrawal, I Kaur, Z Younoszai, ... Digestive diseases and sciences 58, 3017-3023, 2013	344	2013
In-hospital mortality and economic burden associated with hepatic encephalopathy in the United States from 2005 to 2009 M Stepanova, A Mishra, C Venkatesan, ZM Younossi Clinical gastroenterology and hepatology 10 (9), 1034-1041. e1, 2012	296	2012
NASH in lean individuals R Younes, E Bugianesi Seminars in liver disease 39 (01), 086-095, 2019	262	2019
Non‐alcoholic fatty liver disease (NAFLD) is associated with low level of physical activity: a population‐based study L Gerber, M Otgonsuren, A Mishra, C Escheik, A Birerdinc, M Stepanova, ... Alimentary pharmacology & therapeutics 36 (8), 772-781, 2012	250	2012
Predictors of health‐related quality of life in patients with chronic liver disease A Afendy, JB Kallman, M Stepanova, Z Younoszai, RD Aquino, G Bianchi, ... Alimentary pharmacology & therapeutics 30 (5), 469-476, 2009	213	2009
Direct and indirect economic burden of chronic liver disease in the United States M Stepanova, L De Avila, M Afendy, I Younossi, H Pham, R Cable, ... Clinical Gastroenterology and Hepatology 15 (5), 759-766. e5, 2017	200	2017
Improvement of health-related quality of life and work productivity in chronic hepatitis C patients with early and advanced fibrosis treated with ledipasvir and sofosbuvir ZM Younossi, M Stepanova, N Afdhal, KV Kowdley, S Zeuzem, L Henry, ... Journal of hepatology 63 (2), 337-345, 2015	197	2015

Systemet kan ikke utføre handlingen. Prøv på nytt senere.

Artikler 1–20

Sitater per år

Duplikatsitater

Sammenslåtte sitater

Legg til medforfattereMedforfattere

Følg

Sitert av

Medforfattere